Screener
Gyre Therapeutics, Inc. GYRE Total Assets
Total Assets at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Deferred tax assets | 9,284 | 6,873 |
| Long-term certificates of deposit | 28,444 | 23,516 |
| Other assets, noncurrent | 7,344 | 7,624 |
| Total assets | $199,255 | $219,763 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $1,236 | $1,335 |
| Due to related parties | 5,085 | 227 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Gyre Therapeutics, Inc.'s total assets?
- Gyre Therapeutics, Inc. (GYRE) reported total assets of $199.26M in Q2 2026.
- How has Gyre Therapeutics, Inc.'s total assets changed year-over-year?
- Gyre Therapeutics, Inc.'s total assets increased by 30.5% year-over-year, from $152.65M to $199.26M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s total assets?
- Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s total assets has grown at a 18.3% compound annual growth rate (CAGR), from $94.85M to $219.76M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Gyre Therapeutics, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude